Haibin Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Haibin Guo has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Yanqing Xia
Department of Reproductive Medicine Center, Henan Provincial People’s Hospital
8 shared publicationsKe Feng
Department of Reproductive Medicine Center, Henan Provincial People’s Hospital
7 shared publicationsXiaowei Qu
Department of Reproductive Medicine Center, Henan Provincial People’s Hospital
5 shared publicationsCuilian Zhang
Reproductive Medicine Center, Zhengzhou University People’s Hospital, Zhengzhou, China
4 shared publicationsFeng Wan
Department of Reproductive Medicine Center, Henan Provincial People’s Hospital
4 shared publicationsChenchen Cui
Reproductive Medicine Center, Zhengzhou University People’s Hospital, Zhengzhou, China
3 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1937470
A novel frameshift variant in TTC29 associated with total asthenozoospermia and male infertility
Background: Severe sperm motility defects are an important cause of male infertility and are frequently associated with sperm flagellar abnormalities. TTC29 encodes an evolutionarily conserved axonemal protein implicated in sperm flagellar assembly and motility, yet the pathogenic mechanisms of TTC29 variants remain incompletely understood. Methods: A Chinese man with total asthenozoospermia was investigated using whole-exome sequencing, Sanger sequencing, transmission electron microscopy, sperm immunofluorescence, and heterologous expression analysis in HEK293 T cells. The clinical outcome following intracytoplasmic sperm injection (ICSI) was also evaluated. Results: Whole-exome sequencing identified a novel TTC29 frameshift variant (NM_031956.4:c.121dupA; p. Ile41Asnfs*21), which was confirmed by Sanger sequencing. Transmission electron microscopy revealed severe ultrastructural abnormalities involving both the midpiece and principal piece, with disruption of the canonical 9 + 2 axonemal architecture and marked abnormalities of peri-axonemal structures. In representative immunofluorescence images, TTC29 signal was readily detected along the sperm flagellum in the fertile control, whereas a visibly weaker signal was observed in spermatozoa from the proband. Heterologous expression analysis showed little or no detectable production of the expected TTC29 protein product from the mutant construct. Although fertilization was achieved following two ICSI cycles, no clinical pregnancy was obtained. Conclusion: We identified a novel TTC29 frameshift variant associated with total asthenozoospermia and male infertility. Genetic, ultrastructural, and heterologous expression evidence supports a deleterious effect of the identified TTC29 variant, thereby expanding the mutational spectrum of TTC29 -related infertility and providing further insight into the molecular basis of severe sperm motility disorders.
- 27 August 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1937470
Open AccessA novel frameshift variant in TTC29 associated with total asthenozoospermia and male infertility
Background: Severe sperm motility defects are an important cause of male infertility and are frequently associated with sperm flagellar abnormalities. TTC29 encodes an evolutionarily conserved axonemal protein implicated in sperm flagellar assembly and motility, yet the pathogenic mechanisms of TTC29 variants remain incompletely understood. Methods: A Chinese man with total asthenozoospermia was investigated using whole-exome sequencing, Sanger sequencing, transmission electron microscopy, sperm immunofluorescence, and heterologous expression analysis in HEK293 T cells. The clinical outcome following intracytoplasmic sperm injection (ICSI) was also evaluated. Results: Whole-exome sequencing identified a novel TTC29 frameshift variant (NM_031956.4:c.121dupA; p. Ile41Asnfs*21), which was confirmed by Sanger sequencing. Transmission electron microscopy revealed severe ultrastructural abnormalities involving both the midpiece and principal piece, with disruption of the canonical 9 + 2 axonemal architecture and marked abnormalities of peri-axonemal structures. In representative immunofluorescence images, TTC29 signal was readily detected along the sperm flagellum in the fertile control, whereas a visibly weaker signal was observed in spermatozoa from the proband. Heterologous expression analysis showed little or no detectable production of the expected TTC29 protein product from the mutant construct. Although fertilization was achieved following two ICSI cycles, no clinical pregnancy was obtained. Conclusion: We identified a novel TTC29 frameshift variant associated with total asthenozoospermia and male infertility. Genetic, ultrastructural, and heterologous expression evidence supports a deleterious effect of the identified TTC29 variant, thereby expanding the mutational spectrum of TTC29 -related infertility and providing further insight into the molecular basis of severe sperm motility disorders.
- Open Access
- 18 February 2026
- Published by Elsevier in Journal of Advanced Research
- Vol. 89, 693-703
Temporal variability of urinary microcystin-LR concentrations in healthy adult men: Recommendations for sampling strategy
- 18 February 2026
- Published by Elsevier in Journal of Advanced Research
- Vol. 89, 693-703
Open AccessTemporal variability of urinary microcystin-LR concentrations in healthy adult men: Recommendations for sampling strategy
- 19 November 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (12) , 3899-3905
Novel DNAH17 Splice-Site Mutations Truncating the AAA6 Domain Cause Asthenozoospermia with MMAF
To investigate the pathogenicity of splice-site variants in DNAH17, and analyze their impact on sperm morphology and motility, we employed whole-exome sequencing (WES) and Sanger sequencing to identify and validate candidate variants. Computational predictions of splicing defects were performed using varSEAK and MobiDetails. Functional validation was conducted using minigene splicing assays in HEK293T cells. Structural modeling of mutant proteins was performed with AlphaFold3 and visualized by PyMOL. Two novel splice-site variants (DNAH17: c.11677 + 5G > T/c.11677 + 5G > A) were identified in a proband with asthenozoospermia and multiple morphological abnormalities of the sperm flagella (MMAF). Bioinformatics tools predicted disruption of the canonical donor splice site (MaxEntScan score reduction: 54.2% for G > A, 39.5% for G > T; SpliceAI donor loss scores > 0.8). Minigene assays confirmed exon 72 skipping, leading to a frameshift mutation (p.Asn3844Lysfs*13) that truncates the AAA6 domain. This study expands the mutational spectrum of DNAH17-related male infertility by demonstrating that splice-site variants disrupting the AAA6 domain represent a novel pathogenic mechanism underlying asthenozoospermia and MMAF. These findings underscore the necessity of integrating splice-site analysis into genetic diagnostics for male infertility.
- 19 November 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (12) , 3899-3905
Novel DNAH17 Splice-Site Mutations Truncating the AAA6 Domain Cause Asthenozoospermia with MMAF
To investigate the pathogenicity of splice-site variants in DNAH17, and analyze their impact on sperm morphology and motility, we employed whole-exome sequencing (WES) and Sanger sequencing to identify and validate candidate variants. Computational predictions of splicing defects were performed using varSEAK and MobiDetails. Functional validation was conducted using minigene splicing assays in HEK293T cells. Structural modeling of mutant proteins was performed with AlphaFold3 and visualized by PyMOL. Two novel splice-site variants (DNAH17: c.11677 + 5G > T/c.11677 + 5G > A) were identified in a proband with asthenozoospermia and multiple morphological abnormalities of the sperm flagella (MMAF). Bioinformatics tools predicted disruption of the canonical donor splice site (MaxEntScan score reduction: 54.2% for G > A, 39.5% for G > T; SpliceAI donor loss scores > 0.8). Minigene assays confirmed exon 72 skipping, leading to a frameshift mutation (p.Asn3844Lysfs*13) that truncates the AAA6 domain. This study expands the mutational spectrum of DNAH17-related male infertility by demonstrating that splice-site variants disrupting the AAA6 domain represent a novel pathogenic mechanism underlying asthenozoospermia and MMAF. These findings underscore the necessity of integrating splice-site analysis into genetic diagnostics for male infertility.
- 13 October 2025
- Published by Elsevier in Environmental Pollution
- Vol. 386, 127253
Multi-omics analysis reveals fluorinated liquid crystal monomers BDPrB/EDPrB exposure disrupts the steroid biosynthesis function via inhibition of CYP17A1
- 13 October 2025
- Published by Elsevier in Environmental Pollution
- Vol. 386, 127253
Multi-omics analysis reveals fluorinated liquid crystal monomers BDPrB/EDPrB exposure disrupts the steroid biosynthesis function via inhibition of CYP17A1
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Impact of AZFc deletion subtypes on sperm retrieval rates via micro-TESE and ICSI outcomes in non-obstructive azoospermia patients
This study aims to compare the sperm retrieval rate (SRR) achieved through microdissection testicular sperm extraction (micro-TESE) with the outcomes of intracytoplasmic sperm injection (ICSI) in patients with non-obstructive azoospermia (NOA) who exhibit a partial deletion of the azoospermia factor c(AZFc) region on the Y chromosome. From December 2016 to September 2023, the clinical data of patients with NOA who had AZFc deletions, which were identified through high-throughput sequencing, and who underwent micro-TESE were retrospectively analyzed. Based on the results of screening the AZFc region, the patients were categorized into three groups—the gr/gr deletion group (n = 17), the b2/b4 deletion group (n = 62), and the b2/b3 deletion group (n = 11). The SRR, embryo development, and embryo transfer outcomes were compared between the three groups. The SRR in the gr/gr deletion group was significantly lower than that in the b2/b4 deletion group (P = 0.010). Conversely, the SRR in the b2/b4 deletion group and b2/b3 deletion group were relatively high, at 64.5% (40/62) and 54.5(6/11),respectively; however, the number of micro-TESE procedures that extracted sperm with severe morphological abnormalities was 13, resulting in an available sperm rate of only 43.5% (27/62). No significant differences were observed across all groups regarding fertilized oocyte (2PN) rate, 2PN cleavage rate, D3 available embryo rate, high-quality embryo rate, blastocyst formation rate, number of transferred embryos, miscarriage rate, clinical pregnancy rate, or live birth delivery rate (P > 0.05). The micro-TESE outcomes in NOA patients with partial deletions in the AZFc region of the Y chromosome are most significantly negatively impacted by gr/gr deletion.Patients with b2/b4 deletion and b2/b3 deletion type should actively undergo surgical treatment to obtain biological descendants.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Open AccessImpact of AZFc deletion subtypes on sperm retrieval rates via micro-TESE and ICSI outcomes in non-obstructive azoospermia patients
This study aims to compare the sperm retrieval rate (SRR) achieved through microdissection testicular sperm extraction (micro-TESE) with the outcomes of intracytoplasmic sperm injection (ICSI) in patients with non-obstructive azoospermia (NOA) who exhibit a partial deletion of the azoospermia factor c(AZFc) region on the Y chromosome. From December 2016 to September 2023, the clinical data of patients with NOA who had AZFc deletions, which were identified through high-throughput sequencing, and who underwent micro-TESE were retrospectively analyzed. Based on the results of screening the AZFc region, the patients were categorized into three groups—the gr/gr deletion group (n = 17), the b2/b4 deletion group (n = 62), and the b2/b3 deletion group (n = 11). The SRR, embryo development, and embryo transfer outcomes were compared between the three groups. The SRR in the gr/gr deletion group was significantly lower than that in the b2/b4 deletion group (P = 0.010). Conversely, the SRR in the b2/b4 deletion group and b2/b3 deletion group were relatively high, at 64.5% (40/62) and 54.5(6/11),respectively; however, the number of micro-TESE procedures that extracted sperm with severe morphological abnormalities was 13, resulting in an available sperm rate of only 43.5% (27/62). No significant differences were observed across all groups regarding fertilized oocyte (2PN) rate, 2PN cleavage rate, D3 available embryo rate, high-quality embryo rate, blastocyst formation rate, number of transferred embryos, miscarriage rate, clinical pregnancy rate, or live birth delivery rate (P > 0.05). The micro-TESE outcomes in NOA patients with partial deletions in the AZFc region of the Y chromosome are most significantly negatively impacted by gr/gr deletion.Patients with b2/b4 deletion and b2/b3 deletion type should actively undergo surgical treatment to obtain biological descendants.
- Open Access
- 30 June 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1585818
Microdissection testicular sperm extraction–intracytoplasmic sperm injection strategy in patients with Klinefelter syndrome: synchronous or asynchronous?
Objective: The objective of this study was to compare the clinical outcomes of intracytoplasmic sperm injection (ICSI) with fresh versus cryopreserved sperm retrieved via microdissection testicular sperm extraction (mTESE) in patients with Klinefelter syndrome (KS).Design: A retrospective cohort study was conducted.Setting: This study was performed at the Reproductive Medicine Center of Henan Provincial People’s Hospital.Participants: A total of 260 men with KS, including 5 patients with mosaic KS, underwent mTESE,124 of whom successfully provided sperm. These patients were divided into synchronous (fresh sperm) and asynchronous (cryopreserved sperm) groups for ICSI treatment.Interventions: Fresh or cryopreserved sperm were used in the ICSI cycles.Main outcome measures: The primary outcomes were the clinical pregnancy rate, live birth rate, and miscarriage rate. The secondary outcomes were two pronuclei (2PN) embryos, available embryos, and the blastocyst formation rate. The number of oocytes retrieved and metaphase II (MII) oocytes were considered female-related indicators and treated as potential confounding variables in the multivariate analyses, given their influence on embryo development and pregnancy outcomes.Results: A total of 260 KS patients underwent mTESE, with the successful retrieval of sperm suitable for ICSI in assisted reproduction from 124 (47.7%). Among these, 73 had their sperm cryopreserved at low temperature before ICSI, while 51 had their fresh sperm directly used for ICSI. The analysis of 170 treatment cycles revealed no significant differences in baseline characteristics (infertility duration, body mass index (BMI), follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T)) between the groups. Compared with the asynchronous group, the synchronous group had more oocytes retrieved, MII oocytes, gestational sacs, and good-quality embryos. However, there were no significant differences in 2PN embryos, 2PN fertilization rates, total embryos, available embryos, good-quality embryo rates, clinical pregnancy rates, live birth rates, or miscarriage rates between the two groups. LASSO regression and ROC curve analysis demonstrated the limited ability of differential indicators to predict pregnancy outcomes.Conclusions: In KS patients undergoing ICSI, the use of fresh or cryopreserved testicular sperm did not significantly affect pregnancy outcomes. While fresh sperm have advantages in improving certain laboratory parameters, their overall ability to predict pregnancy outcomes is limited.
- 30 June 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1585818
Open AccessMicrodissection testicular sperm extraction–intracytoplasmic sperm injection strategy in patients with Klinefelter syndrome: synchronous or asynchronous?
Objective: The objective of this study was to compare the clinical outcomes of intracytoplasmic sperm injection (ICSI) with fresh versus cryopreserved sperm retrieved via microdissection testicular sperm extraction (mTESE) in patients with Klinefelter syndrome (KS).Design: A retrospective cohort study was conducted.Setting: This study was performed at the Reproductive Medicine Center of Henan Provincial People’s Hospital.Participants: A total of 260 men with KS, including 5 patients with mosaic KS, underwent mTESE,124 of whom successfully provided sperm. These patients were divided into synchronous (fresh sperm) and asynchronous (cryopreserved sperm) groups for ICSI treatment.Interventions: Fresh or cryopreserved sperm were used in the ICSI cycles.Main outcome measures: The primary outcomes were the clinical pregnancy rate, live birth rate, and miscarriage rate. The secondary outcomes were two pronuclei (2PN) embryos, available embryos, and the blastocyst formation rate. The number of oocytes retrieved and metaphase II (MII) oocytes were considered female-related indicators and treated as potential confounding variables in the multivariate analyses, given their influence on embryo development and pregnancy outcomes.Results: A total of 260 KS patients underwent mTESE, with the successful retrieval of sperm suitable for ICSI in assisted reproduction from 124 (47.7%). Among these, 73 had their sperm cryopreserved at low temperature before ICSI, while 51 had their fresh sperm directly used for ICSI. The analysis of 170 treatment cycles revealed no significant differences in baseline characteristics (infertility duration, body mass index (BMI), follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T)) between the groups. Compared with the asynchronous group, the synchronous group had more oocytes retrieved, MII oocytes, gestational sacs, and good-quality embryos. However, there were no significant differences in 2PN embryos, 2PN fertilization rates, total embryos, available embryos, good-quality embryo rates, clinical pregnancy rates, live birth rates, or miscarriage rates between the two groups. LASSO regression and ROC curve analysis demonstrated the limited ability of differential indicators to predict pregnancy outcomes.Conclusions: In KS patients undergoing ICSI, the use of fresh or cryopreserved testicular sperm did not significantly affect pregnancy outcomes. While fresh sperm have advantages in improving certain laboratory parameters, their overall ability to predict pregnancy outcomes is limited.
- 28 December 2024
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 486, 137033
Chronic exposure to liquid crystal monomer EBCN at environmentally relevant concentrations induces testicular dysfunction via the gut-testis axis
- 28 December 2024
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 486, 137033
Chronic exposure to liquid crystal monomer EBCN at environmentally relevant concentrations induces testicular dysfunction via the gut-testis axis
- Open Access
- 27 September 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (18) , e18580
Loss‐of‐function variant in TDRD6 cause male infertility with severe oligo‐astheno‐teratozoospermia in human and mice
Oligo‐astheno‐teratozoospermia (OAT) is a common cause of male infertility, but the genetic basis of most OAT cases is still unknown. Here, one homozygous loss‐of‐function (LOF) variant in TDRD6, c.G1825T/p.Gly609X, was identified in an infertile patient with severe OAT by whole‐exome sequencing (WES) and Sanger confirmation. Furthermore, Tdrd6‐mutant mice (p.Gly615X; equivalent to p.Gly609X in human TDRD6) were generated. Remarkably, the Tdrd6‐mutated mice mimicked the severe OAT symptoms of the patient. In addition, the architecture of chromatoid bodies (CBs) were disrupted in round spermatids from Tdrd6‐mutant mice, leading to blocked spermatogenesis in the round spermatids. The assembly of PIWIL1, TDRD1, TDRD7 and DDX25 in CBs was disturbed in the Tdrd6‐mutant mice. Applying immunoprecipitation‐mass spectrometry (IP‐MS), we identified some TDRD6‐interacting partners, including CB proteins TDRD7, MAEL and PCBP1. Moreover, we described the assisted reproductive technology (ART) outcomes of the infertile patient and his partner. Altogether, our findings provide necessary evidences to support the idea that the homozygous LOF variant in TDRD6 induces male infertility with severe OAT, suggesting that TDRD6 could be a useful genetic diagnostic target for male infertility.
- 27 September 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (18) , e18580
Open AccessLoss‐of‐function variant in TDRD6 cause male infertility with severe oligo‐astheno‐teratozoospermia in human and mice
Oligo‐astheno‐teratozoospermia (OAT) is a common cause of male infertility, but the genetic basis of most OAT cases is still unknown. Here, one homozygous loss‐of‐function (LOF) variant in TDRD6, c.G1825T/p.Gly609X, was identified in an infertile patient with severe OAT by whole‐exome sequencing (WES) and Sanger confirmation. Furthermore, Tdrd6‐mutant mice (p.Gly615X; equivalent to p.Gly609X in human TDRD6) were generated. Remarkably, the Tdrd6‐mutated mice mimicked the severe OAT symptoms of the patient. In addition, the architecture of chromatoid bodies (CBs) were disrupted in round spermatids from Tdrd6‐mutant mice, leading to blocked spermatogenesis in the round spermatids. The assembly of PIWIL1, TDRD1, TDRD7 and DDX25 in CBs was disturbed in the Tdrd6‐mutant mice. Applying immunoprecipitation‐mass spectrometry (IP‐MS), we identified some TDRD6‐interacting partners, including CB proteins TDRD7, MAEL and PCBP1. Moreover, we described the assisted reproductive technology (ART) outcomes of the infertile patient and his partner. Altogether, our findings provide necessary evidences to support the idea that the homozygous LOF variant in TDRD6 induces male infertility with severe OAT, suggesting that TDRD6 could be a useful genetic diagnostic target for male infertility.
- Open Access
- 18 January 2024
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (1) , e2364
Compound heterozygous mutations in CFTR causing congenital bilateral absence of the vas deferens in a Chinese pedigree
Background: Cystic fibrosis (CF) is an autosomal recessive disorder rarely found in Asian populations. Most males with CF are infertile because of obstructive azoospermia (OA) caused by congenital bilateral absence of the vas deferens (CBAVD). Compound heterozygous mutations of cystic fibrosis transmembrane conductance regulator (CFTR) are among the most common pathogenic factors in CBAVD. However, few genealogical analyses have been performed.Methods: In this study, whole‐exome sequencing and cosegregation analysis were performed in a Chinese pedigree involving two siblings with CBAVD. Moreover, in vitro gene expressions were used to analyze the pathogenicity of a novel CFTR mutation.Results: We identified compound heterozygous mutations of CFTR comprising the known disease‐causing variant c.1210‐11T>G (also known as IVS9‐5 T) and c.2144delA;p.q715fs in two siblings with CBAVD. To verify the effects in vitro, we transfected vectors expressing wild‐type and mutated CFTR into 293T cells. The results showed that the CFTR protein containing the frameshift mutation (c.2144delA) was 60 kD smaller. With testicular sperm aspiration/intracytoplasmic sperm injection‐embryo transfer (TESA/ICSI‐ET), both CBAVD patients fathered healthy offspring.Conclusion: Our study revealed that compound heterozygous mutations of CFTR are involved in CBAVD, expanding the known CFTR gene mutation spectrum of CBAVD patients and providing more evidence that compound heterozygous mutations can cause familial CBAVD.
- 18 January 2024
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (1) , e2364
Open AccessCompound heterozygous mutations in CFTR causing congenital bilateral absence of the vas deferens in a Chinese pedigree
Background: Cystic fibrosis (CF) is an autosomal recessive disorder rarely found in Asian populations. Most males with CF are infertile because of obstructive azoospermia (OA) caused by congenital bilateral absence of the vas deferens (CBAVD). Compound heterozygous mutations of cystic fibrosis transmembrane conductance regulator (CFTR) are among the most common pathogenic factors in CBAVD. However, few genealogical analyses have been performed.Methods: In this study, whole‐exome sequencing and cosegregation analysis were performed in a Chinese pedigree involving two siblings with CBAVD. Moreover, in vitro gene expressions were used to analyze the pathogenicity of a novel CFTR mutation.Results: We identified compound heterozygous mutations of CFTR comprising the known disease‐causing variant c.1210‐11T>G (also known as IVS9‐5 T) and c.2144delA;p.q715fs in two siblings with CBAVD. To verify the effects in vitro, we transfected vectors expressing wild‐type and mutated CFTR into 293T cells. The results showed that the CFTR protein containing the frameshift mutation (c.2144delA) was 60 kD smaller. With testicular sperm aspiration/intracytoplasmic sperm injection‐embryo transfer (TESA/ICSI‐ET), both CBAVD patients fathered healthy offspring.Conclusion: Our study revealed that compound heterozygous mutations of CFTR are involved in CBAVD, expanding the known CFTR gene mutation spectrum of CBAVD patients and providing more evidence that compound heterozygous mutations can cause familial CBAVD.
- Open Access
- 3 August 2023
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 27 (20) , 3107-3116
A novel mutation in PCD ‐associated gene DNAAF3 causes male infertility due to asthenozoospermia
Primary ciliary dyskinesia (PCD) is a rare autosomal‐recessive disease manifested with recurrent infections of respiratory tract and infertility. DNAAF3 is identified as a novel gene associated with PCD and different mutations in DNAAF3 results in different clinical features of PCD patients, such as situs inversus, sinusitis and bronchiectasis. However, the sperm phenotypic characteristics of PCD males are generally poorly investigated. Our reproductive medicine centre received a case of PCD patient with infertility, who presented with sinusitis, recurrent infections of the lower airway and severe asthenozoospermia; However, no situs inversus was found in the patient. A novel homozygous mutation in DNAAF3 (c.551T>A; p.V184E) was identified in the PCD patient by whole‐exome sequencing. Subsequent Sanger sequencing further confirmed that the DNAAF3 had a homozygous missense variant in the fifth exon. Transmission electron microscopy and immunostaining analysis of the sperms from the patient showed a complete absence of outer dynein arms and partial absence of inner dynein arms, which resulted in the reduction in sperm motility. However, this infertility was overcome by intracytoplasmic sperm injections, as his wife achieved successful pregnancy. These findings showed that the PCD‐associated pathogenic mutation within DNAAF3 also causes severe asthenozoospermia and male infertility ultimately due to sperm flagella axoneme defect in humans. Our study not only contributes to understand the sperm phenotypic characteristics of patients with DNAAF3 mutations but also expands the spectrum of DNAAF3 mutations and may contribute to the genetic diagnosis and therapy for infertile patient with PCD.
- 3 August 2023
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 27 (20) , 3107-3116
Open AccessA novel mutation in PCD ‐associated gene DNAAF3 causes male infertility due to asthenozoospermia
Primary ciliary dyskinesia (PCD) is a rare autosomal‐recessive disease manifested with recurrent infections of respiratory tract and infertility. DNAAF3 is identified as a novel gene associated with PCD and different mutations in DNAAF3 results in different clinical features of PCD patients, such as situs inversus, sinusitis and bronchiectasis. However, the sperm phenotypic characteristics of PCD males are generally poorly investigated. Our reproductive medicine centre received a case of PCD patient with infertility, who presented with sinusitis, recurrent infections of the lower airway and severe asthenozoospermia; However, no situs inversus was found in the patient. A novel homozygous mutation in DNAAF3 (c.551T>A; p.V184E) was identified in the PCD patient by whole‐exome sequencing. Subsequent Sanger sequencing further confirmed that the DNAAF3 had a homozygous missense variant in the fifth exon. Transmission electron microscopy and immunostaining analysis of the sperms from the patient showed a complete absence of outer dynein arms and partial absence of inner dynein arms, which resulted in the reduction in sperm motility. However, this infertility was overcome by intracytoplasmic sperm injections, as his wife achieved successful pregnancy. These findings showed that the PCD‐associated pathogenic mutation within DNAAF3 also causes severe asthenozoospermia and male infertility ultimately due to sperm flagella axoneme defect in humans. Our study not only contributes to understand the sperm phenotypic characteristics of patients with DNAAF3 mutations but also expands the spectrum of DNAAF3 mutations and may contribute to the genetic diagnosis and therapy for infertile patient with PCD.